Skip to Content

Earlier Access to Effective Treatments for Children with MS Reduces the Burden of Long-Term Disability

New research presented at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood significantly reduces long-term disability in multiple sclerosis patients.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top